亚虹医药: 江苏亚虹医药科技股份有限公司2025年第一次临时股东大会会议资料

Core Points - The company is holding a shareholders' meeting to ensure the orderly conduct of the meeting and the rights of shareholders [1][2] - The meeting will include a voting process combining on-site and online methods, with results to be announced afterward [3][5] - The company plans to use remaining raised funds totaling RMB 87.04 million to permanently supplement working capital [11][13] Group 1: Meeting Procedures - Shareholders and their representatives must arrive 30 minutes early for registration and verification of attendance [1] - The meeting will have a structured agenda, allowing shareholders to speak only with the host's permission and within a time limit [2] - Voting will be conducted through both on-site and online methods, with results published in a subsequent announcement [3][5] Group 2: Fund Usage - The company intends to use RMB 87.04 million of the remaining raised funds for working capital, which includes interest income and investment returns [11][13] - The total amount of excess raised funds is RMB 310.73 million, with the proposed usage not exceeding 30% of this total [13][14] - The company assures that this fund usage will not affect the implementation of investment projects and complies with relevant regulations [14]